Table 1.

Clinical characteristics of the enrolled patients

n	45
Age (±SD)	67.5 ± 3.5
PSA (±SD)	13 ± 10.7
G.S.	6	1
	7	28
	8	9
	9	7
T	T1c	12
	T2a	1
	T2b	7
	T2c	7
	T3a	17
	T3b	1
Risk group	Intermediate	16
	High	29

PSA: prostate specific antigen.

G.S. Gleason score.

T:T category of TNM Classification of Malignant Tumours 7th Edition.

Risk group: D’Amico risk stratification.